Momentous Data For Oxford/Novavax Malaria Vaccine
First To Achieve WHO's 75% Efficacy Goal
A year to the day since the first dose of its COVID-19 vaccine was given, Oxford University's Jenner Institute has unveiled stellar findings from a Phase IIb trial of its malaria vaccine.
